Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M. Monjazeb, Karen Kelly, Alexander D. Borowsky et al.|Nature Communications|2023Cited by 21
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB StudyJonathan W. Riess, David R. Gandara, Miguel López de Rodas et al.|JTO Clinical and Research Reports|2024Cited by 2
P15.04 A Phase I/IB Trial of Pembrolizumab and Trametinib Focused on Advanced KRAS Mutant Non-Small Cell Lung CancerJonathan W. Riess, David R. Gandara, Kurt A. Schalper et al.|Journal of Thoracic Oncology|2021Cited by 1